RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
-14.25%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$5.67B
AUM Growth
-$1.54B
Cap. Flow
+$149M
Cap. Flow %
2.62%
Top 10 Hldgs %
45.45%
Holding
105
New
10
Increased
9
Reduced
7
Closed
8

Top Buys

1
BLU
BELLUS Health Inc.
BLU
$82.4M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$55.9M
3
LIAN
LianBio American Depositary Shares
LIAN
$47.2M
4
RLMD icon
Relmada Therapeutics
RLMD
$45.1M
5
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
$34.8M

Top Sells

1
AVIR icon
Atea Pharmaceuticals
AVIR
$190M
2
TGTX icon
TG Therapeutics
TGTX
$35.9M
3
VERV
Verve Therapeutics
VERV
$21M
4
CTMX icon
CytomX Therapeutics
CTMX
$17.8M
5
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$10.2M

Sector Composition

1 Healthcare 98.88%
2 Financials 0.78%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BOLT icon
76
Bolt Biotherapeutics
BOLT
$9.29M
$11.7M 0.21%
118,916
– –
OTIC
77
DELISTED
Otonomy, Inc.
OTIC
$11.6M 0.21%
5,600,000
+3,968,365
+243% +$8.25M
SPRY icon
78
ARS Pharmaceuticals
SPRY
$1.08B
$11.6M 0.2%
1,742,186
– –
VERV
79
DELISTED
Verve Therapeutics
VERV
$11.4M 0.2%
310,284
-570,000
-65% -$21M
RNA icon
80
Avidity Biosciences
RNA
$6.12B
$10.1M 0.18%
423,616
– –
HLTH
81
DELISTED
Cue Health Inc. Common Stock
HLTH
$10.1M 0.18%
750,000
– –
FLACU
82
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$9.92M 0.17%
1,000,000
– –
ARYE
83
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$9.7M 0.17%
1,000,000
– –
CNCE
84
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$9.56M 0.17%
3,033,603
– –
IMA
85
ImageneBio, Inc. Common Stock
IMA
$153M
$9.41M 0.17%
62,500
– –
COGT icon
86
Cogent Biosciences
COGT
$1.83B
$8.8M 0.16%
1,025,641
– –
PHAS
87
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$7.44M 0.13%
2,850,000
– –
FVAM
88
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
$7.39M 0.13%
750,000
– –
ATXS icon
89
Astria Therapeutics
ATXS
$394M
$6.8M 0.12%
1,262,193
– –
ENTX icon
90
Entera Bio
ENTX
$92.7M
$6.62M 0.12%
2,353,000
– –
OBIO icon
91
Orchestra BioMed
OBIO
$147M
$6.3M 0.11%
625,000
– –
CMPX icon
92
Compass Therapeutics
CMPX
$466M
$5.86M 0.1%
+1,849,518
New +$5.86M
TCRX icon
93
TScan Therapeutics
TCRX
$106M
$5.65M 0.1%
1,255,317
– –
CGEM icon
94
Cullinan Oncology
CGEM
$456M
$5.4M 0.1%
350,000
– –
BMEA icon
95
Biomea Fusion
BMEA
$114M
$3.73M 0.07%
500,000
– –
CVRX icon
96
CVRx
CVRX
$204M
$3.36M 0.06%
275,000
– –
SYRS
97
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.93M 0.05%
90,000
– –
AVIR icon
98
Atea Pharmaceuticals
AVIR
$275M
– –
-5,427,655
Closed -$190M
CTMX icon
99
CytomX Therapeutics
CTMX
$350M
– –
-3,500,000
Closed -$17.8M
MLTX icon
100
MoonLake Immunotherapeutics
MLTX
$3.78B
– –
-700,000
Closed -$6.97M
1 2 3
4
5